Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1382 to 1431 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hypoxia-inducible factor-3 alpha isoform a; inhibitory pas domain protein. [source:refseq;acc:nm\_152794]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1007\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5707.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6249.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09485\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
i-kappa-b-interacting ras-like protein 2. [source:refseq;acc:nm\_017595]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1197\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5721.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6217.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0867\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
immature colon carcinoma transcript 1 (digestion substraction 1) (ds- 1). [source:swissprot;acc:q14197]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1045\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5364.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5862.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09279\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
immunoglobulin-binding protein 1 (cd79a-binding protein 1) (b cell signal transduction molecule alpha 4) (alpha 4 protein). [source:swissprot;acc:p78318]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1257\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5438.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5893.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0837\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
imp2 inner mitochondrial membrane protease-like; inner mitochondrial membrane peptidase 2 like. [source:refseq;acc:nm\_032549]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
357\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5061.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5950.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17567\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin 4. [source:refseq;acc:nm\_024658]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1403\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5613.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6050.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07785\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin 7; ran-binding protein 7. [source:refseq;acc:nm\_006391]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1421\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5628.53\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6063.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0773\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
importin 8; ran-binding protein 8. [source:refseq;acc:nm\_006390]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1422\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin 9. [source:refseq;acc:nm\_018085]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2860\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin alpha-1 subunit (karyopherin alpha-1 subunit) (srp1-beta) (rag cohort protein 2) (nucleoprotein interactor 1) (npi-1). [source:swissprot;acc:p52294]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1142\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5789.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6302.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0886\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin alpha-2 subunit (karyopherin alpha-2 subunit) (srp1-alpha) (rag cohort protein 1). [source:swissprot;acc:p52292]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2780\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin alpha-3 subunit (karyopherin alpha-3 subunit) (srp1-gamma). [source:swissprot;acc:o00505]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
801\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6456.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7169.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1105\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin alpha-4 subunit (karyopherin alpha-4 subunit) (qip1 protein). [source:swissprot;acc:o00629]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
803\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6455.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7167.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11045\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin alpha-6 subunit (karyopherin alpha-5 subunit). [source:swissprot;acc:o15131]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1126\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5792.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6305.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08867\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin beta-1 subunit (karyopherin beta-1 subunit) (nuclear factor p97) (importin 90). [source:swissprot;acc:q14974]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
797\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6834.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7590.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin beta-2 subunit (karyopherin beta-2 subunit) (transportin) (m9 region interaction protein) (mip). [source:swissprot;acc:q92973]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2149\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5778.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6086.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0532\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin beta-3 subunit (karyopherin beta-3 subunit) (ran-binding protein 5). [source:swissprot;acc:o00410]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
904\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6167.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6785.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10031\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
importin-alpha re-exporter (chromosome segregation 1-like protein) (cellular apoptosis susceptibility protein). [source:swissprot;acc:p55060]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
701\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7802.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8731.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11913\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
indolethylamine n-methyltransferase (ec 2.1.1.49) (aromatic alkylamine n-methyltransferase) (indolamine n-methyltransferase) (arylamine n- methyltransferase) (amine n-methyltransferase). [source:swissprot;acc:o95050]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1676\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5791.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6193.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0694\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
inflammation-related g protein-coupled receptor ex33. [source:refseq;acc:nm\_020370]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2714\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
inhibitor of growth family, member 1-like; inhibitor of growth 1-like. [source:refseq;acc:nm\_001564]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2739\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4877.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4890.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00264\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
inhibitor of growth family, member 1; inhibitor of growth 1. [source:refseq;acc:nm\_005537]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2736\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4887.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4902.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00296\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
inorganic pyrophosphatase (ec 3.6.1.1) (pyrophosphate phospho- hydrolase) (ppase). [source:swissprot;acc:q15181]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1901\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5204.25\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5530.11\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06261\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
inorganic pyrophosphatase 2 isoform 1. [source:refseq;acc:nm\_176869]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1902\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
inosine-5'-monophosphate dehydrogenase 1 (ec 1.1.1.205) (imp dehydrogenase 1) (impdh-i) (impd 1). [source:swissprot;acc:p20839]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2245\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5776.96\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6049.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0472\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
inosine-5'-monophosphate dehydrogenase 2 (ec 1.1.1.205) (imp dehydrogenase 2) (impdh-ii) (impd 2). [source:swissprot;acc:p12268]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2243\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
inositol polyphosphate 5-phosphatase ocrl-1 (ec 3.1.3.36) (lowe's oculocerebrorenal syndrome protein). [source:swissprot;acc:q01968]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1981\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5475.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5800.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05939\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
inositol polyphosphate multikinase. [source:refseq;acc:nm\_152230]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1542\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5466\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5865.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07306\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type 1 isoform b; inositol polyphosphate-4-phosphatase, type i, 107kd; 4-phosphatase i; inositol polyphosphate-4-phosphatase i. [source:refseq;acc:nm\_001566]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
559\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6167.93\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7007.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.13615\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type ii, 105kd; inositol polyphosphate 4-phosphatase ii; 4-phosphatase ii. [source:refseq;acc:nm\_003866]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
557\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
inositol polyphosphate-5-phosphatase; phosphatidylinositol polyphosphate 5-phosphatase type iv; phosphatidylinositol (4,5) bisphosphate 5-phosphatase. [source:refseq;acc:nm\_019892]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2912\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase (ec 3.1.3.25) (impase) (imp) (inositol monophosphatase) (lithium-sensitive myo-inositol monophosphatase a1). [source:swissprot;acc:p29218]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1717\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6069.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6484.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06842\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase 2 (ec 3.1.3.25) (impase 2) (imp 2) (inositol monophosphatase 2) (myo-inositol monophosphatase a2). [source:swissprot;acc:o14732]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1716\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6070.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6485.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06844\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
insulin gene enhancer protein isl-1 (islet-1). [source:swissprot;acc:p20663]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2626\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7424.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7534.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01479\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
insulin gene enhancer protein isl-2 (islet-2). [source:swissprot;acc:q96a47]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2638\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7433.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7525.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0123\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
integral membrane protein 2a (e25 protein). [source:swissprot;acc:o43736]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
986\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6362.64\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6976.1\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09642\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
integral membrane protein 2b (transmembrane protein bri) [contains: abri/adan amyloid peptide]. [source:swissprot;acc:q9y287]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
984\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
integral membrane protein 2c (transmembrane protein bri3) (npd018). [source:swissprot;acc:q9nqx7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
985\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
integral membrane protein cii-3b. [source:sptrembl;acc:o75609]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2511\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6256.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6415.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02535\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
integrin alpha-3 precursor (galactoprotein b3) (gapb3) (vla-3 alpha chain) (cd49c). [source:swissprot;acc:p26006]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3224\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
integrin alpha-6 precursor (vla-6) (cd49f). [source:swissprot;acc:p23229]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3158\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
integrin alpha-7 precursor. [source:swissprot;acc:q13683]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2978\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
integrin beta-1 precursor (fibronectin receptor beta subunit) (cd29 antigen) (integrin vla-4 beta subunit). [source:swissprot;acc:p05556]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2905\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
integrin beta-2 precursor (cell surface adhesion glycoproteins lfa- 1/cr3/p150,95 beta-subunit) (cd18) (complement receptor c3 beta- subunit). [source:swissprot;acc:p05107]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2873\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
integrin beta-3 precursor (platelet membrane glycoprotein iiia) (gpiiia) (cd61 antigen). [source:swissprot;acc:p05106]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3195\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
integrin beta-7 precursor. [source:swissprot;acc:p26010]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2951\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
integrin-linked protein kinase 1 (ec 2.7.1.-) (ilk-1) (59 kda serine/threonine protein kinase) (p59ilk). [source:swissprot;acc:q13418]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1869\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
interferon-related developmental regulator 2 (skmc15 protein). [source:swissprot;acc:q12894]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1787\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5386.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5744.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06652\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
interleukin enhancer binding factor 2; nuclear factor of activated t-cells, 45-kda. [source:refseq;acc:nm\_004515]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2930\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
interleukin enhancer-binding factor 1 (cellular transcription factor ilf-1). [source:swissprot;acc:q01167]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1090\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5651.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6164.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09086\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/